Related Experiment Videos
Mini-dose intrathecal morphine for post-cesarean section analgesia.
1Department of Anesthesiology, National Taiwan University Hospital, Taipei, R.O.C.
Ma Zui Xue Za Zhi = Anaesthesiologica Sinica
|December 1, 1991
Summary
Mini-dose intrathecal morphine effectively extends analgesia duration after Cesarean sections, showing a linear dose-response relationship. While pruritus is a common side effect, neonatal outcomes remain unaffected, indicating a favorable risk-benefit profile.
Area of Science:
- Anesthesiology
- Obstetrics
- Pharmacology
Background:
- Post-Cesarean section pain management is crucial for maternal recovery.
- Intrathecal morphine is used for analgesia but optimal mini-dosing requires further study.
Purpose of the Study:
- To determine the dose-response relationship of mini-dose intrathecal morphine for post-Cesarean section analgesia.
- To evaluate the efficacy and safety of varying intrathecal morphine doses.
Main Methods:
- A randomized study involving 63 patients undergoing Cesarean section.
- Intrathecal administration of 0.5% hyperbaric bupivacaine with varying doses of morphine (0-0.125 mg).
- Assessment of analgesia duration, pain scores, analgesic quality, and adverse effects.
Main Results:
- Intrathecal morphine significantly increased analgesia duration and reduced 24-hour pain scores compared to the control group.
- A significant linear dose-response relationship was observed between morphine dose and analgesia duration (r² = 0.64, p < 0.05).
- Higher morphine doses (0.075-0.125 mg) provided better analgesic quality and effectiveness, with pruritus being the most common maternal side effect.
Conclusions:
- Mini-dose intrathecal morphine offers effective and dose-dependent analgesia following Cesarean section.
- The studied doses of intrathecal morphine do not adversely affect neonatal condition.
- Intrathecal morphine presents a favorable option for post-Cesarean section pain relief, with careful consideration of potential side effects like pruritus.